Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.
2.
4.
5.
11.

Cloning and expression of NDV hemagglutinin-neuraminidase cDNA in a baculovirus expression vector system.

Nagy E, Derbyshire JB, Dobos P, Krell PJ.

Virology. 1990 Jun;176(2):426-38.

PMID:
2345960
12.

Temperature-sensitive mutants of Newcastle disease virus altered in HN glycoprotein size, stability, or antigenic maturity.

Peeples ME, Glickman RL, Gallagher JP, Bratt MA.

Virology. 1988 May;164(1):284-9.

PMID:
3363869
15.

Structure and function of a membrane anchor-less form of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus.

Mirza AM, Sheehan JP, Hardy LW, Glickman RL, Iorio RM.

J Biol Chem. 1993 Oct 5;268(28):21425-31.

16.

Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals.

Peeters BP, de Leeuw OS, Verstegen I, Koch G, Gielkens AL.

Vaccine. 2001 Feb 8;19(13-14):1616-27.

PMID:
11166884
17.
18.

Role of a conserved sequence in the maturation and function of the NDV HN glycoprotein.

Sergel T, McGinnes L, Morrison T.

Virus Res. 1993 Dec;30(3):281-94.

PMID:
8109161
19.

Identification of amino acid residues important to the neuraminidase activity of the HN glycoprotein of Newcastle disease virus.

Iorio RM, Syddall RJ, Glickman RL, Riel AM, Sheehan JP, Bratt MA.

Virology. 1989 Nov;173(1):196-204.

PMID:
2479168
Items per page

Supplemental Content

Write to the Help Desk